Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jennifer Couzin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Geographic Areas

United States

Organizations

Procedures

Living Beings

Mice

Activities & Behaviors

Physiology

Genetic Predisposition to Disease

Concepts & Ideas

Genes & Molecular Sequences

Human Genome

Objects

Universities

Phenomena

RNA Interference

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
2
Normile, Dennis
1
Schirber, Michael
1
Enserink, Martin
1
Bagla, Pallava

Sign-in to see all Coauthors

Publications

TOP 3
Couzin Jennifer
Public health. Stronger research just one item on drug agency's wish list.
Couzin Jennifer
Biomarkers. Metabolite in urine may point to high-risk prostate cancer.
Couzin Jennifer
Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jennifer Couzin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Couzin Jennifer
Public health. Stronger research just one item on drug agency's wish list.
Science (New York, N.Y.) 2009;323(5921):1549.
2009: Couzin Jennifer
Biomarkers. Metabolite in urine may point to high-risk prostate cancer.
Science (New York, N.Y.) 2009;323(5916):865.
2009: Couzin Jennifer
Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells.
Science (New York, N.Y.) 2009;323(5914):568.
2009: Couzin Jennifer
Social science. With isolation comes ill health.
Science (New York, N.Y.) 2009;323(5913):456-7.
2009: Couzin Jennifer
Social science. Friendship as a health factor.
Science (New York, N.Y.) 2009;323(5913):454-7.
2009: Couzin Jennifer
The transition. CDC's Gerberding makes an early exit.
Science (New York, N.Y.) 2009;323(5912):324-5.
2009: Couzin Jennifer
Research funding. For many scientists, the Madoff scandal suddenly hits home.
Science (New York, N.Y.) 2009;323(5910):25.
2008: Couzin Jennifer
Human genetics. Interest rises in DNA copy number variations--along with questions.
Science (New York, N.Y.) 2008;322(5906):1314.
2008: Couzin Jennifer
Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Science (New York, N.Y.) 2008;322(5904):1039.
2008: Couzin Jennifer
Foundations. Economic woes threaten to deflate plans for 2009.
Science (New York, N.Y.) 2008;322(5903):841.
2008: Couzin Jennifer
Genetics. DNA test for breast cancer risk draws criticism.
Science (New York, N.Y.) 2008;322(5900):357.
2008: Couzin Jennifer
Clinical trials and tribulations. Cholesterol veers off script.
Science (New York, N.Y.) 2008;322(5899):220-3.
2008: Couzin Jennifer
Social science. Do voter surveys underestimate the impact of racial bias?
Science (New York, N.Y.) 2008;322(5899):180-1.
2008: Couzin Jennifer
U.S. election. McCain, Obama present their wars on cancer.
Science (New York, N.Y.) 2008;321(5895):1432.
2008: Couzin Jennifer
Genetic privacy. Whole-genome data not anonymous, challenging assumptions.
Science (New York, N.Y.) 2008;321(5894):1278.
2008: Couzin Jennifer
Cancer research. Can fasting blunt chemotherapy's debilitating side effects?
Science (New York, N.Y.) 2008;321(5893):1146-7.
2008: Couzin Jennifer
Sociology. Survey finds citations growing narrower as journals move online.
Science (New York, N.Y.) 2008;321(5887):329.
2008: Couzin Jennifer
Epilepsy. When death strikes without warning.
Science (New York, N.Y.) 2008;321(5885):31-3.
2008: Couzin Jennifer
Parkinson's disease. Streamlined clinical trials, from a home computer.
Science (New York, N.Y.) 2008;320(5880):1143.
2008: Couzin Jennifer
Medicine. Bypassing medicine to treat diabetes.
Science (New York, N.Y.) 2008;320(5875):438-40.
2008: Couzin Jennifer
MicroRNAs make big impression in disease after disease.
Science (New York, N.Y.) 2008;319(5871):1782-4.
2008: Couzin Jennifer
Genetic risk. With new disease genes, a bounty of questions.
Science (New York, N.Y.) 2008;319(5871):1754-5.
2008: Couzin Jennifer; Normile Dennis
Scientific misconduct. Two papers from Korean lab found to lack 'scientific truth'.
Science (New York, N.Y.) 2008;319(5869):1468-9.
2008: Couzin Jennifer
Evolution. Crossing the divide.
Science (New York, N.Y.) 2008;319(5866):1034-6.
2008: Couzin Jennifer
Genetics. Once shunned, test for Alzheimer's risk headed to market.
Science (New York, N.Y.) 2008;319(5866):1022-3.
2008: Couzin Jennifer
Clinical research. Deaths in diabetes trial challenge a long-held theory.
Science (New York, N.Y.) 2008;319(5865):884-5.
2008: Couzin Jennifer
Living in the danger zone.
Science (New York, N.Y.) 2008;319(5864):748-9.
2008: Couzin Jennifer
Science and commerce. Hoping for a glimpse of what's ahead.
Science (New York, N.Y.) 2008;319(5861):276-7.
2008: Couzin Jennifer
Science and commerce. Gene tests for psychiatric risk polarize researchers.
Science (New York, N.Y.) 2008;319(5861):274-7.
2008: Couzin Jennifer
Science and the next U.S. president. Republican: Mike Huckabee.
Science (New York, N.Y.) 2008;319(5859):26-7.
2007: Couzin Jennifer
Research policy. NIH weighs big changes in peer review.
Science (New York, N.Y.) 2007;318(5857):1708-9.
2007: Couzin Jennifer
Clinical research. ALS trial raises questions about promising drug.
Science (New York, N.Y.) 2007;318(5854):1227.
2007: Couzin Jennifer
Immunology. Testing the line between too much and too little.
Science (New York, N.Y.) 2007;318(5851):740-1.
2007: Couzin Jennifer
Medicine. Tumor suppressor may also affect gestational diabetes.
Science (New York, N.Y.) 2007;318(5851):729.
2007: Couzin Jennifer
Nutrition. Dietary guidelines spark flap over fish consumption.
Science (New York, N.Y.) 2007;318(5850):550-1.
2007: Couzin Jennifer
Biodefense research. Lapses in biosafety spark concern.
Science (New York, N.Y.) 2007;317(5844):1487.
2007: Couzin Jennifer
Oncology. In their prime, and dying of cancer.
Science (New York, N.Y.) 2007;317(5842):1160-2.
2007: Couzin Jennifer
Genetics. Epidemiologist sees flaws in papers on genes and gender.
Science (New York, N.Y.) 2007;317(5841):1020-1.
2007: Couzin Jennifer
Medicine. The big chill.
Science (New York, N.Y.) 2007;317(5839):743-5.
2007: Couzin Jennifer
Women's health. Seeking clarity in hormones' effects on the heart.
Science (New York, N.Y.) 2007;316(5833):1826.
2007: Couzin Jennifer
Drug safety. Heart attack risk overshadows a popular diabetes therapy.
Science (New York, N.Y.) 2007;316(5831):1550-1.
2007: Couzin Jennifer; Kaiser Jocelyn
Genome-wide association. Closing the net on common disease genes.
Science (New York, N.Y.) 2007;316(5826):820-2.
2007: Couzin Jennifer
Genetics. Erasing microRNAs reveals their powerful punch.
Science (New York, N.Y.) 2007;316(5824):530.
2007: Miller Greg; Couzin Jennifer
NIH budget. Peer review under stress.
Science (New York, N.Y.) 2007;316(5823):358-9.
2007: Couzin Jennifer; Miller Greg
NIH budget. Boom and bust.
Science (New York, N.Y.) 2007;316(5823):356-61.
2007: Couzin Jennifer
Psychopharmacology. Study questions antidepressant risks.
Science (New York, N.Y.) 2007;316(5823):354.
2007: Couzin Jennifer
Clinical research. Testing a novel strategy against Parkinson's disease.
Science (New York, N.Y.) 2007;315(5820):1778.
2007: Couzin Jennifer
2008 budget. Senators offer sympathetic ear to complaints on NIH's fiscal slide.
Science (New York, N.Y.) 2007;315(5819):1646.
2007: Couzin Jennifer
Polar science. Opening doors to native knowledge.
Science (New York, N.Y.) 2007;315(5818):1518-9.
2007: Couzin Jennifer
Cancer research. Tight budget takes a toll on U.S.-funded clinical trials.
Science (New York, N.Y.) 2007;315(5816):1202-3.
2007: Couzin Jennifer
Diagnostics. Amid debate, gene-based cancer test approved.
Science (New York, N.Y.) 2007;315(5814):924.
2007: Couzin Jennifer
Cancer research. Probing the roots of race and cancer.
Science (New York, N.Y.) 2007;315(5812):592-4.
2007: Couzin Jennifer
Developmental biology. In embryos, pancreas and liver reach full size in different ways.
Science (New York, N.Y.) 2007;315(5812):587.
2007: Couzin Jennifer
Human genetics. In Asians and whites, gene expression varies by race.
Science (New York, N.Y.) 2007;315(5809):173-4.
2006: Couzin Jennifer
Scientific publishing. Don't pretty up that picture just yet.
Science (New York, N.Y.) 2006;314(5807):1866-8.
2006: Couzin Jennifer
Breakthrough of the year. Breakdown of the year: scientific fraud.
Science (New York, N.Y.) 2006;314(5807):1853.
2006: Couzin Jennifer
Molecular biology. Three methods add up to one new way to genetically engineer fruit flies.
Science (New York, N.Y.) 2006;314(5804):1371.
2006: Couzin Jennifer
Developmental biology. Teams identify cardiac 'stem cell'.
Science (New York, N.Y.) 2006;314(5803):1225.
2006: Couzin Jennifer
Genetics. Unraveling pain's DNA.
Science (New York, N.Y.) 2006;314(5799):585-6.
2006: Kaiser Jocelyn; Couzin Jennifer
Public health. Gerberding defends her transformation of CDC.
Science (New York, N.Y.) 2006;314(5797):246-7.
2006: Couzin Jennifer
Nobel Prize in Physiology or Medicine. Method to silence genes earns loud praise.
Science (New York, N.Y.) 2006;314(5796):34.
2006: Couzin Jennifer
Cancer. T cells a boon for colon cancer prognosis.
Science (New York, N.Y.) 2006;313(5795):1868-9.
2006: Couzin Jennifer
Clinical trials. A shot of bone marrow can help the heart.
Science (New York, N.Y.) 2006;313(5794):1715-6.
2006: Couzin Jennifer
Genomics. Microarray data reproduced, but some concerns remain.
Science (New York, N.Y.) 2006;313(5793):1559.
2006: Couzin Jennifer
FDA. Proposed guidelines for emergency research aim to quell confusion.
Science (New York, N.Y.) 2006;313(5792):1372-3.
2006: Couzin Jennifer
Scientific misconduct. Truth and consequences.
Science (New York, N.Y.) 2006;313(5791):1222-6.
2006: Couzin Jennifer
Medicine. Desperate measures.
Science (New York, N.Y.) 2006;313(5789):904-7.
2006: Couzin Jennifer
Molecular imaging. New optics strategies cut through diffraction barrier.
Science (New York, N.Y.) 2006;313(5788):748-9.
2006: Couzin Jennifer; Kaiser Jocelyn
2007 U.S. budget. NIH prepares for lean budget after Senate vote.
Science (New York, N.Y.) 2006;313(5786):424.
2006: Couzin Jennifer
Cancer research. Fake data, but could the idea still be right?
Science (New York, N.Y.) 2006;313(5784):154.
2006: Couzin Jennifer
Genomics. The HapMap gold rush: researchers mine a rich deposit.
Science (New York, N.Y.) 2006;312(5777):1131.
2006: Couzin Jennifer
Molecular biology. RNAi safety comes under scrutiny.
Science (New York, N.Y.) 2006;312(5777):1121.
2006: Couzin Jennifer
infectious disease. RU-486-linked deaths open debate about risky bacteria.
Science (New York, N.Y.) 2006;312(5776):986.
2006: Couzin Jennifer
Veterans Administration. Texas earmark allots millions to disputed theory of Gulf War illness.
Science (New York, N.Y.) 2006;312(5774):668.
2006: Couzin Jennifer
Biomedical research. Bone disease gene finally found.
Science (New York, N.Y.) 2006;312(5773):514-5.
2006: Unger Katherine; Couzin Jennifer
Scientific misconduct. Even retracted papers endure.
Science (New York, N.Y.) 2006;312(5770):40-1.
2006: Couzin Jennifer; Unger Katherine
Scientific misconduct. Cleaning up the paper trail.
Science (New York, N.Y.) 2006;312(5770):38-43.
2006: Couzin Jennifer
Immunology. Diabetes studies conflict on power of spleen cells.
Science (New York, N.Y.) 2006;311(5768):1694.
2006: Kaiser Jocelyn; Couzin Jennifer
U.S. science policy. Cancer institute director tapped for FDA.
Science (New York, N.Y.) 2006;311(5768):1692.
2006: Couzin Jennifer
Infectious diseases. Report concludes polio drugs are needed--after disease is eradicated.
Science (New York, N.Y.) 2006;311(5767):1539.
2006: Couzin Jennifer
Cell biology. The prion protein has a good side? You bet.
Science (New York, N.Y.) 2006;311(5764):1091.
2006: Couzin Jennifer
Women's health. Study yields murky signals on low-fat diets and disease.
Science (New York, N.Y.) 2006;311(5762):755.
2006: Couzin Jennifer; Schirber Michael
Scientific misconduct. Fraud upends oral cancer field, casting doubt on prevention trial.
Science (New York, N.Y.) 2006;311(5760):448-9.
2006: Couzin Jennifer; Holden Constance; Chong Sei
Scientific publishing. Hwang aftereffects reverberate at journals.
Science (New York, N.Y.) 2006;311(5759):321.
2006: Couzin Jennifer
Research management. U.S. rules on accounting for grants amount to more than a hill of beans.
Science (New York, N.Y.) 2006;311(5758):168-9.
2006: Normile Dennis; Vogel Gretchen; Couzin Jennifer
Cloning. South Korean team's remaining human stem cell claim demolished.
Science (New York, N.Y.) 2006;311(5758):156-7.
2006: Couzin Jennifer
Stem cells. ...and how the problems eluded peer reviewers and editors.
Science (New York, N.Y.) 2006;311(5757):23-4.
2005: Couzin Jennifer
Drug testing. Massive trial of Celebrex seeks to settle safety concerns.
Science (New York, N.Y.) 2005;310(5756):1890-1.
2005: Couzin Jennifer
Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld.
Science (New York, N.Y.) 2005;310(5755):1755.
2005: Couzin Jennifer
U.S. higher education. Professor sues university over building he is funding.
Science (New York, N.Y.) 2005;310(5751):1101-2.
2005: Couzin Jennifer
Cancer biology. A new cancer player takes the stage.
Science (New York, N.Y.) 2005;310(5749):766-7.
2005: Couzin Jennifer
Scientific misconduct. MIT terminates researcher over data fabrication.
Science (New York, N.Y.) 2005;310(5749):758.
2005: Couzin Jennifer
Genomics. New haplotype map may overhaul gene hunting.
Science (New York, N.Y.) 2005;310(5748):601.
2005: Couzin Jennifer
Drug regulation. Plan B: A collision of science and politics.
Science (New York, N.Y.) 2005;310(5745):38-9.
2005: Couzin Jennifer; Kaiser Jocelyn
U.S. biomedical policy. NCI head to fill in at FDA after Crawford resignation.
Science (New York, N.Y.) 2005;309(5744):2142-3.
2005: Couzin Jennifer
Stem cells. Another route to oocytes?
Science (New York, N.Y.) 2005;309(5743):1983.
2005: Couzin Jennifer
Breast cancer. Fine-tuning breast density measures.
Science (New York, N.Y.) 2005;309(5741):1665.
2005: Couzin Jennifer
Breast cancer. Dissecting a hidden breast cancer risk.
Science (New York, N.Y.) 2005;309(5741):1664-6.
2005: Couzin Jennifer
Physiology. Boosting gene extends mouse life span.
Science (New York, N.Y.) 2005;309(5739):1310-1.
2005: Couzin Jennifer
The brains behind blockbusters.
Science (New York, N.Y.) 2005;309(5735):728.
2005: Couzin Jennifer
Veterans affairs. Gene bank proposal draws support--and a competitor.
Science (New York, N.Y.) 2005;309(5735):684-5.
2005: Couzin Jennifer
Structural biology. Ten centers chosen to decode protein structures.
Science (New York, N.Y.) 2005;309(5732):230.
2005: Couzin Jennifer
How much can human life span be extended?
Science (New York, N.Y.) 2005;309(5731):83.
2005: Couzin Jennifer
To what extent are genetic variation and personal health linked?
Science (New York, N.Y.) 2005;309(5731):81.
2005: Couzin Jennifer
Foundations. Joining forces for brain tumor research.
Science (New York, N.Y.) 2005;309(5731):32.
2005: Couzin Jennifer
Cell biology: The ins and outs of exosomes.
Science (New York, N.Y.) 2005;308(5730):1862-3.
2005: Couzin Jennifer
U.S. science budget. VA asked to bolster mental health research.
Science (New York, N.Y.) 2005;308(5728):1526-7.
2005: Couzin Jennifer
Clinical research. Advocating, the clinical way.
Science (New York, N.Y.) 2005;308(5724):940-2.
2005: Couzin Jennifer
Public health. A heavyweight battle over CDC's obesity forecasts.
Science (New York, N.Y.) 2005;308(5723):770-1.
2005: Couzin Jennifer
Molecular biology. Human RNA slows down a primate retrovirus.
Science (New York, N.Y.) 2005;308(5721):480-1.
2005: Couzin Jennifer
AIDS research. IOM panel clears HIV prevention study.
Science (New York, N.Y.) 2005;308(5720):334.
2005: Couzin Jennifer
Academic jobs. Tenured UCLA professor under fire.
Science (New York, N.Y.) 2005;308(5718):37.
2005: Couzin Jennifer
Drug discovery. Magnificent obsession.
Science (New York, N.Y.) 2005;307(5716):1712-5.
2005: Couzin Jennifer
Diabetes research. Researchers puzzle over possible effect of Gleevec.
Science (New York, N.Y.) 2005;307(5716):1711.
2005: Couzin Jennifer
American Association for the Advancement of Science meeting. DNA tells story of heart drug failure.
Science (New York, N.Y.) 2005;307(5713):1191.
2005: Couzin Jennifer
Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
Science (New York, N.Y.) 2005;307(5713):1183-5.
2005: Couzin Jennifer; Kaiser Jocelyn
Gene therapy. As Gelsinger case ends, gene therapy suffers another blow.
Science (New York, N.Y.) 2005;307(5712):1028.
2005: Couzin Jennifer
Drug development. Lupus drug company asks FDA for second chance.
Science (New York, N.Y.) 2005;307(5711):835.
2005: Couzin Jennifer
Drug safety. Gaps in the safety net.
Science (New York, N.Y.) 2005;307(5707):196-8.
2005: Couzin Jennifer
Clinical trials. Facing criticism, industry offers to share data.
Science (New York, N.Y.) 2005;307(5707):189.
2004: Couzin Jennifer
Molecular biology. Long-sought enzyme found, revealing new gene switch on histones.
Science (New York, N.Y.) 2004;306(5705):2171.
2004: Couzin Jennifer
Clinical trials. Halt of Celebrex study threatens drug's future, other trials.
Science (New York, N.Y.) 2004;306(5705):2170.
2004: Couzin Jennifer
Clinical trials. Nail-biting time for trials of COX-2 drugs.
Science (New York, N.Y.) 2004;306(5702):1673-5.
2004: Couzin Jennifer
Medicine. Estrogen's ties to COX-2 may explain heart disease gender gap.
Science (New York, N.Y.) 2004;306(5700):1277.
2004: Couzin Jennifer
Molecular biology. RNAi shows cracks in its armor.
Science (New York, N.Y.) 2004;306(5699):1124-5.
2004: Couzin Jennifer
Drug testing. Regulators talk up plans for drug biomarkers ...
Science (New York, N.Y.) 2004;306(5699):1119.
2004: Couzin Jennifer
Medicine. Sperm-targeting vaccine blocks male fertility in monkeys.
Science (New York, N.Y.) 2004;306(5699):1117.
2004: Couzin Jennifer
Infectious diseases. Ethicists to guide rationing of flu vaccine.
Science (New York, N.Y.) 2004;306(5698):960-1.
2004: Couzin Jennifer
Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors.
Science (New York, N.Y.) 2004;306(5695):384-5.
2004: Couzin Jennifer
Diabetes. Islet transplants face test of time.
Science (New York, N.Y.) 2004;306(5693):34-7.
2004: Couzin Jennifer
Epidemiology. VA advisers link Gulf War illnesses to neurotoxins.
Science (New York, N.Y.) 2004;306(5693):26-7.
2004: Couzin Jennifer
Drug research. Legislators propose a registry to track clinical trials from start to finish.
Science (New York, N.Y.) 2004;305(5691):1695.
2004: Couzin Jennifer
Pharmacogenomics. Cancer sharpshooters rely on DNA tests for a better aim.
Science (New York, N.Y.) 2004;305(5688):1222-3.
2004: Couzin Jennifer
Human subjects research. Pediatric study of ADHD drug draws high-level public review.
Science (New York, N.Y.) 2004;305(5687):1088-9.
2004: Couzin Jennifer
Cancer research. Proposed leukemia stem cell encounters a blast of scrutiny.
Science (New York, N.Y.) 2004;305(5686):929.
2004: Couzin Jennifer
Basic and clinical immunology meeting. Genes crisscross disease lines.
Science (New York, N.Y.) 2004;305(5685):773.
2004: Couzin Jennifer
Basic and clinical immunology meeting. And action! Dendritic cells go live.
Science (New York, N.Y.) 2004;305(5685):772-3.
2004: Couzin Jennifer
Basic and clinical immunology meeting. An old favorite is resurrected: regulatory T cells take the stage.
Science (New York, N.Y.) 2004;305(5685):772.
2004: Couzin Jennifer
Biomedicine. An end to the prion debate? Don't count on it.
Science (New York, N.Y.) 2004;305(5684):589.
2004: Couzin Jennifer
Psychopharmacology. Volatile chemistry: children and antidepressants.
Science (New York, N.Y.) 2004;305(5683):468-70.
2004: Couzin Jennifer
Putting tolerance to the test.
Science (New York, N.Y.) 2004;305(5681):194-6.
2004: Couzin Jennifer
Scientific community. U.S. prosecutes professors for shipping microbes.
Science (New York, N.Y.) 2004;305(5681):159.
2004: Couzin Jennifer
Research on aging. Gene links calorie deprivation and long life in rodents.
Science (New York, N.Y.) 2004;304(5678):1731.
2004: Couzin Jennifer
Immunology. Unexpectedly, ancient molecule tied to asthma.
Science (New York, N.Y.) 2004;304(5677):1577.
2004: Couzin Jennifer
Huntington's disease. Unorthodox clinical trials meld science and care.
Science (New York, N.Y.) 2004;304(5672):816-7.
2004: Couzin Jennifer
Genomics. Consensus emerges on HapMap strategy.
Science (New York, N.Y.) 2004;304(5671):671-3.
2004: Couzin Jennifer
AIDS meeting. Edict limits U.S. speakers at Bangkok conference.
Science (New York, N.Y.) 2004;304(5670):499-500.
2004: Couzin Jennifer; Vogel Gretchen
Cell therapy. Renovating the heart.
Science (New York, N.Y.) 2004;304(5668):192-4.
2004: Couzin Jennifer
Genetics. Two new asthma genes uncovered.
Science (New York, N.Y.) 2004;304(5668):185-7.
2004: Couzin Jennifer
Biomedical research. IG report faults handling of Veterans Affairs funds.
Science (New York, N.Y.) 2004;304(5667):29.
2004: Couzin Jennifer
Biodefense. U.S. agencies unveil plan for biosecurity peer review.
Science (New York, N.Y.) 2004;303(5664):1595.
2004: Couzin Jennifer
Reproductive biology. Textbook rewrite? Adult mammals may produce eggs after all.
Science (New York, N.Y.) 2004;303(5664):1593.
2004: Couzin Jennifer
Genetics. Hybrid mosquitoes suspected in West Nile virus spread.
Science (New York, N.Y.) 2004;303(5663):1451.
2004: Couzin Jennifer
Scientific community. Aging research's family feud.
Science (New York, N.Y.) 2004;303(5662):1276-9.
2004: Couzin Jennifer
U.S. appointments. FDA's popular chief to take on Medicare.
Science (New York, N.Y.) 2004;303(5662):1269.
2004: Couzin Jennifer
2004 annual meeting. RNA rules metabolite production.
Science (New York, N.Y.) 2004;303(5661):1122.
2004: Couzin Jennifer
The new math of clinical trials.
Science (New York, N.Y.) 2004;303(5659):784-6.
2003: Couzin Jennifer
Genome sequencing. Cow ambles to the sequencing house.
Science (New York, N.Y.) 2003;302(5653):2050.
2003: Couzin Jennifer
Biomedical research. Defunded VA grants restored; Wray returns to Texas.
Science (New York, N.Y.) 2003;302(5652):1872.
2003: Couzin Jennifer
Biomedical research. VA's controversial chief of research said to be leaving.
Science (New York, N.Y.) 2003;302(5649):1306.
2003: Couzin Jennifer
Estrogen research. The great estrogen conundrum.
Science (New York, N.Y.) 2003;302(5648):1136-8.
2003: Couzin Jennifer
Medicine. In a first, infected mice recover from prion disease.
Science (New York, N.Y.) 2003;302(5646):763-5.
2003: Couzin Jennifer
Choices--and uncertainties--for women with BRCA mutations.
Science (New York, N.Y.) 2003;302(5645):592.
2003: Couzin Jennifer
The twists and turns in BRCA's path.
Science (New York, N.Y.) 2003;302(5645):591-3.
2003: Couzin Jennifer
Aging research: is long life in the blood?
Science (New York, N.Y.) 2003;302(5644):373-5.
2003: Couzin Jennifer
Molecular medicine. NIH dives into drug discovery.
Science (New York, N.Y.) 2003;302(5643):218-21.
2003: Couzin Jennifer
Medicine. Sugary cloak protects platelets from the cold.
Science (New York, N.Y.) 2003;301(5639):1457.
2003: Couzin Jennifer
Genomics. Sequencers examine priorities.
Science (New York, N.Y.) 2003;301(5637):1176-7.
2003: Couzin Jennifer
2004 science budget. Congress wants the twain to meet.
Science (New York, N.Y.) 2003;301(5632):444.
2003: Couzin Jennifer
Medicine. Drug deals diabetes a one-two punch.
Science (New York, N.Y.) 2003;301(5631):290.
2003: Couzin Jennifer
Medicine. A sigh of relief for painkillers.
Science (New York, N.Y.) 2003;301(5630):150.
2003: Couzin Jennifer
Biomedical research. VA shaken by plan to cut grants, cultivate the 'stars'.
Science (New York, N.Y.) 2003;301(5629):24-5.
2003: Couzin Jennifer
Smallpox immunization. Panel urges caution over heart problems.
Science (New York, N.Y.) 2003;300(5628):2013-5.
2003: Couzin Jennifer
Clinical trials. Diabetes' brave new world.
Science (New York, N.Y.) 2003;300(5627):1862-5.
2003: Couzin Jennifer
Developmental biology. Purified signaling protein stimulates stem cell proliferation.
Science (New York, N.Y.) 2003;300(5620):722.
2003: Couzin Jennifer
Biomedical research. Canceling grants, VA research chief shakes the system.
Science (New York, N.Y.) 2003;300(5619):574-5.
2003: Couzin Jennifer
Royal society. Report deplores growth in academic patenting.
Science (New York, N.Y.) 2003;300(5618):406.
2003: Couzin Jennifer
RNA interference. New screen nets 'Hedgehog' genes.
Science (New York, N.Y.) 2003;299(5615):1961.
2003: Couzin Jennifer
West Nile virus. Blood banks in a 'race against the mosquitoes'.
Science (New York, N.Y.) 2003;299(5614):1824.
2003: Couzin Jennifer
Clinical trials. New rule triggers debate over best way to test drugs.
Science (New York, N.Y.) 2003;299(5613):1651-3.
2003: Couzin Jennifer
Functional genomics. How to make sense of sequence.
Science (New York, N.Y.) 2003;299(5613):1642.
2003: Couzin Jennifer
Cancer risk. Review rules out abortion-cancer link.
Science (New York, N.Y.) 2003;299(5612):1498.
2003: Couzin Jennifer
Medicine. A clash over genes that foretell metastasis.
Science (New York, N.Y.) 2003;299(5609):1005.
2003: Couzin Jennifer
Medicine. Tracing the steps of metastasis, cancer's menacing ballet.
Science (New York, N.Y.) 2003;299(5609):1002-6.
2003: Couzin Jennifer
RNA interference. Mini RNA molecules shield mouse liver from hepatitis.
Science (New York, N.Y.) 2003;299(5609):995.
2003: Couzin Jennifer
Research funding. Expert panel urges a boost for Smithsonian science.
Science (New York, N.Y.) 2003;299(5604):180.
2003: Couzin Jennifer
Human subjects. Crossing a frontier: research on the dead.
Science (New York, N.Y.) 2003;299(5603):29-30.
2002: Couzin Jennifer
Breakthrough of the year. Small RNAs make big splash.
Science (New York, N.Y.) 2002;298(5602):2296-7.
2002: Couzin Jennifer
Cell biology. Chaos reigns in RNA transcription.
Science (New York, N.Y.) 2002;298(5598):1538.
2002: Couzin Jennifer; Enserink Martin
Women's health. More questions about hormone replacement.
Science (New York, N.Y.) 2002;298(5595):942.
2002: Couzin Jennifer
Human genome. HapMap launched with pledges of $100 million.
Science (New York, N.Y.) 2002;298(5595):941-2.
2002: Couzin Jennifer
Cancer drugs. Smart weapons prove tough to design.
Science (New York, N.Y.) 2002;298(5593):522-5.
2002: Couzin Jennifer
Biomedical appointments. White House adviser tapped to head FDA.
Science (New York, N.Y.) 2002;298(5591):36-7.
2002: Couzin Jennifer
Cancer immunotherapy. Select T cells, given space, shrink tumors.
Science (New York, N.Y.) 2002;297(5589):1973.
2002: Couzin Jennifer; Bagla Pallava
Patent laws. Report urges leeway for developing world.
Science (New York, N.Y.) 2002;297(5588):1791.
2002: Couzin Jennifer
Nutrition research. IOM panel weighs in on diet and health.
Science (New York, N.Y.) 2002;297(5588):1788-9.
2002: Couzin Jennifer
Genome research. NSF's ark draws alligators, algae, and wasps.
Science (New York, N.Y.) 2002;297(5587):1638-9.
2002: Couzin Jennifer
Profile: Barbara Hatch Rosenberg. Unconventional detective bears down on a killer.
Science (New York, N.Y.) 2002;297(5585):1264-5.
2002: Couzin Jennifer
Molecular biology. In yeast, prions' killer image doesn't apply.
Science (New York, N.Y.) 2002;297(5582):758-61.
2002: Couzin Jennifer
Bioterrorism. A call for restraint on biological data.
Science (New York, N.Y.) 2002;297(5582):749-51.
2002: Couzin Jennifer
Virology. Active poliovirus baked from scratch.
Science (New York, N.Y.) 2002;297(5579):174-5.
2002: Couzin Jennifer
Cancer research. Nanoparticles cut tumors' supply lines.
Science (New York, N.Y.) 2002;296(5577):2314-5.
2002: Couzin Jennifer
Quirks of fetal environment felt decades later.
Science (New York, N.Y.) 2002;296(5576):2167-9.
2002: Couzin Jennifer
Immunology. Plant a few cells, sprout a thymus.
Science (New York, N.Y.) 2002;296(5576):2120-1.
2002: Couzin Jennifer
Genomics. New mapping project splits the community.
Science (New York, N.Y.) 2002;296(5572):1391-3.
2002: Couzin Jennifer
Immunology. Gently soothing a savage immune system.
Science (New York, N.Y.) 2002;296(5567):456-8.
2002: Couzin Jennifer
Protein structure. Harmless proteins twist into troublemakers.
Science (New York, N.Y.) 2002;296(5565):28-9.
2002: Couzin Jennifer
Genomics. Taking aim at Celera's shotgun.
Science (New York, N.Y.) 2002;295(5561):1817.
2002: Couzin Jennifer
Microbiology. Weight of the world on microbes' shoulders.
Science (New York, N.Y.) 2002;295(5559):1444-5.
2002: Couzin Jennifer
Biomedical ethics. Study of brain dead sparks debate.
Science (New York, N.Y.) 2002;295(5558):1210-1.
2002: Couzin Jennifer
Wanted: pig transplants that work.
Science (New York, N.Y.) 2002;295(5557):1008.
2002: Couzin Jennifer
Cell biology. Molecular motors move in mysterious ways.
Science (New York, N.Y.) 2002;295(5556):780-1.
2002: Couzin Jennifer
Cell biology. Stripping the nucleolus down to its proteins.
Science (New York, N.Y.) 2002;295(5554):422.

Sign-in to see more